| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |